# NOBOX

## Overview
NOBOX is a gene that encodes the NOBOX oogenesis homeobox protein, a transcription factor crucial for ovarian development and function. This protein is characterized by its homeodomain, which facilitates DNA binding, and is involved in the regulation of genes essential for folliculogenesis, such as GDF9 and BMP15 (Choi2006Characterization; Bayne2015GDF9). NOBOX is specifically expressed in oocytes and plays a pivotal role in the transition from primordial to primary follicles, a critical step in female fertility (Bouali2016NOBOX; Bouilly2011Novel). Mutations in the NOBOX gene have been linked to primary ovarian insufficiency (POI), highlighting its importance in maintaining normal ovarian function and oocyte survival (Bouilly2011Novel; Sassi2021Compound). The protein's ability to interact with other proteins and its potential post-translational modifications suggest a complex regulatory role in oocyte development (Choi2006Characterization).

## Structure
The NOBOX protein is characterized by its homeodomain, a DNA-binding motif that includes a highly conserved asparagine residue at position 51, which is crucial for its DNA binding activity (Choi2006Characterization). This homeodomain is similar to those found in other homeoproteins, suggesting that NOBOX binds DNA in a structurally similar manner (Choi2006Characterization). The primary structure of NOBOX includes a proline-rich C terminus, which contains putative SH3 and WW domains that may facilitate protein-protein interactions (Choi2006Characterization). These domains are similar to those found in other proteins involved in nuclear localization and binding to other proteins, such as Esx1 (Choi2006Characterization).

NOBOX may undergo post-translational modifications, such as phosphorylation, which can affect its activity and stability. Additionally, splice variant isoforms of NOBOX can exist, potentially altering its functional properties. The presence of these domains and potential modifications suggests a complex tertiary structure that supports its role as a transcription factor in oocyte development. However, specific details on the secondary, tertiary, and quaternary structures of NOBOX are not provided in the available context.

## Function
The NOBOX gene encodes a transcription factor that plays a critical role in ovarian development and function. It is specifically expressed in oocytes and is essential for the transition from primordial to primary follicles, a process known as folliculogenesis (Bouali2016NOBOX; Bouilly2011Novel). NOBOX regulates the expression of several key genes involved in this process, including GDF9, BMP15, and others, by binding to specific DNA sequences known as NOBOX Binding Elements (NBE) (Choi2006Characterization; Bayne2015GDF9). 

In healthy human cells, NOBOX is active in the nucleus, where it influences the transcription of genes critical for oocyte survival and follicle development (Bouali2016NOBOX). The protein's homeodomain allows it to bind DNA and regulate gene expression, which is crucial for the breakdown of oocyte nests into individual primordial follicles, a key step in female fertility (Bayne2015GDF9). Disruption in NOBOX function can lead to defects in follicle development and oocyte survival, contributing to conditions such as primary ovarian insufficiency (POI) (Bouilly2011Novel; Sassi2021Compound).

## Clinical Significance
Mutations in the NOBOX gene are significantly associated with premature ovarian insufficiency (POI), a condition affecting approximately 1% of women under 40, characterized by early ovarian dysfunction and infertility. NOBOX mutations can lead to impaired folliculogenesis, resulting in conditions such as primary amenorrhea and infertility due to disrupted oocyte development (Bouilly2015New; Bouali2016NOBOX). Specific mutations, such as p.Arg355His, have been shown to disrupt NOBOX's DNA-binding ability, which is crucial for its role as a transcriptional regulator in early folliculogenesis (Qin2007NOBOX).

Studies have identified various NOBOX mutations, including missense and truncating mutations, that impair its function, leading to POI. These mutations can result in a loss of function, affecting the regulation of key genes involved in ovarian development, such as GDF9 and BMP15 (Bouilly2011Novel). The genetic basis of POI is complex, with NOBOX mutations contributing to its heterogeneity and heritability (Qin2007NOBOX). Additionally, environmental factors like prenatal hypoxia can alter NOBOX expression through epigenetic modifications, further impacting ovarian function (Yao2022HypoHydroxymethylation).

## Interactions
The NOBOX protein is a transcription factor that interacts with both nucleic acids and other proteins to regulate gene expression crucial for oocyte development and folliculogenesis. NOBOX binds specifically to DNA sequences known as NOBOX binding elements (NBEs), which include the consensus sequence TAATTG. This interaction is essential for the regulation of genes such as GDF9 and POU5F1, which are important for germ cell maintenance and follicle formation (Choi2006Characterization).

Mutations in NOBOX, such as p.R303X, result in a truncated protein that lacks part of the homeodomain, significantly impairing its DNA binding capability and reducing transcriptional activity on target promoters like GDF9 (Bouilly2011Novel). NOBOX also interacts with the FOXL2 protein, forming a complex that regulates pivotal ovarian genes involved in folliculogenesis. This interaction is mediated through their DNA-binding domains and affects the transcriptional activity of shared target promoters (Bouilly2014NOBOX).

NOBOX's C terminus contains putative SH3 and WW domains, suggesting potential protein-protein interactions that may enhance its transcriptional activity by interacting with other oocyte-specific proteins (Choi2006Characterization).


## References


[1. (Bayne2015GDF9) Rosemary A. L. Bayne, Hazel L. Kinnell, Shiona M. Coutts, Jing He, Andrew J. Childs, and Richard A. Anderson. Gdf9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel nobox transcript. PLOS ONE, 10(3):e0119819, March 2015. URL: http://dx.doi.org/10.1371/journal.pone.0119819, doi:10.1371/journal.pone.0119819. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0119819)

[2. (Bouali2016NOBOX) N. Bouali, B. Francou, J. Bouligand, B. Lakhal, I. Malek, M. Kammoun, J. Warszawski, S. Mougou, A. Saad, and A. Guiochon‐Mantel. <scp>nobox</scp> is a strong autosomal candidate gene in tunisian patients with primary ovarian insufficiency. Clinical Genetics, 89(5):608–613, March 2016. URL: http://dx.doi.org/10.1111/cge.12750, doi:10.1111/cge.12750. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.12750)

[3. (Bouilly2011Novel) Justine Bouilly, Anne Bachelot, Isabelle Broutin, Philippe Touraine, and Nadine Binart. Novel nobox loss-of-function mutations account for 6.2. Human Mutation, 32(10):1108–1113, September 2011. URL: http://dx.doi.org/10.1002/humu.21543, doi:10.1002/humu.21543. This article has 89 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21543)

[4. (Sassi2021Compound) Asma Sassi, Julie Désir, Sarah Duerinckx, Julie Soblet, Sonia Van Dooren, Maryse Bonduelle, Marc Abramowicz, and Anne Delbaere. Compound heterozygous null mutations of nobox in sisters with delayed puberty and primary amenorrhea. Molecular Genetics &amp; Genomic Medicine, September 2021. URL: http://dx.doi.org/10.1002/mgg3.1776, doi:10.1002/mgg3.1776. This article has 3 citations.](https://doi.org/10.1002/mgg3.1776)

[5. (Qin2007NOBOX) Yingying Qin, Youngsok Choi, Han Zhao, Joe Leigh Simpson, Zi-Jiang Chen, and Aleksandar Rajkovic. Nobox homeobox mutation causes premature ovarian failure. The American Journal of Human Genetics, 81(3):576–581, September 2007. URL: http://dx.doi.org/10.1086/519496, doi:10.1086/519496. This article has 206 citations.](https://doi.org/10.1086/519496)

[6. (Bouilly2014NOBOX) Justine Bouilly, Reiner A. Veitia, and Nadine Binart. Nobox is a key foxl2 partner involved in ovarian folliculogenesis. Journal of Molecular Cell Biology, 6(2):175–177, March 2014. URL: http://dx.doi.org/10.1093/jmcb/mju006, doi:10.1093/jmcb/mju006. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/jmcb/mju006)

[7. (Choi2006Characterization) Youngsok Choi and Aleksandar Rajkovic. Characterization of nobox dna binding specificity and its regulation of gdf9 and pou5f1 promoters. Journal of Biological Chemistry, 281(47):35747–35756, November 2006. URL: http://dx.doi.org/10.1074/jbc.M604008200, doi:10.1074/jbc.m604008200. This article has 111 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M604008200)

[8. (Bouilly2015New) Justine Bouilly, Florence Roucher-Boulez, Anne Gompel, Hélène Bry-Gauillard, Kemal Azibi, Cherif Beldjord, Catherine Dodé, Jérôme Bouligand, Anne Guiochon Mantel, Annie-Claude Hécart, Brigitte Delemer, Jacques Young, and Nadine Binart. New nobox mutations identified in a large cohort of women with primary ovarian insufficiency decrease kit-l expression. The Journal of Clinical Endocrinology &amp; Metabolism, 100(3):994–1001, March 2015. URL: http://dx.doi.org/10.1210/jc.2014-2761, doi:10.1210/jc.2014-2761. This article has 45 citations.](https://doi.org/10.1210/jc.2014-2761)

[9. (Yao2022HypoHydroxymethylation) Changfang Yao, Likui Lu, Yiting Ji, Yingying Zhang, Weisheng Li, Yajun Shi, Jinliu Liu, Miao Sun, and Fei Xia. Hypo-hydroxymethylation of nobox is associated with ovarian dysfunction in rat offspring exposed to prenatal hypoxia. Reproductive Sciences, 29(5):1424–1436, March 2022. URL: http://dx.doi.org/10.1007/s43032-022-00866-6, doi:10.1007/s43032-022-00866-6. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s43032-022-00866-6)